📰 Genentech News
Page 206 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
February 7, 2023
AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced prestigious new grants from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Target ALS Foundation (Target ALS) supporting research programs to ...
February 6, 2023
California HR veteran has become a student again at Western Digital
February 6, 2023
Investegate announcements from Oxford BioDynamics, OBD Prostate Screening EpiSwitch Blood Test Update
February 6, 2023
Alzheimer's disease has a devastating impact on patients, their families, and society. Early diagnosis and intervention are vital to reduce the risk of admission to 24-hour care facilities, maximize independence and connect with support agencies, and reduce family care providers' sadness, depression, and despair.
February 4, 2023
Freedom from recurrence or reablation and safety outcome were similar at 12 months regardless of whether patients had a recent cancer diagnosis or were on anthracyclines.
February 4, 2023
Follow the StarTribune for the news, photos and videos from the Twin Cities and beyond.
February 2, 2023
DeciBio’s Antibody-Drug Conjugates 2023 Industry Survey points to progress in ADC development. Respondents anticipate lower regulatory,...
February 2, 2023
Case Name: Genentech, Inc. v. Sandoz Inc., No. 2022-1595, 2022 WL 17839055 (Fed. Cir. Dec. 22, 2022) (Circuit Judges Newman, Lourie, and Prost presiding; Opinion by Lourie, J.;...
February 2, 2023
Cell-free DNA concentration is significantly increased in the first 2 weeks after surgery but these higher levels do not seem to interfere with monitoring of circulating tumor DNA for prognostic purposes.